📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. (2020)

First Author: Scott C

Attributed to: Microbubble Enhanced Imaging and Therapeutic Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1008716

PubMed Identifier: 32780760

Publication URI: http://europepmc.org/abstract/MED/32780760

Type: Journal Article/Review

Volume: 16

Parent Publication: PLoS pathogens

Issue: 8

ISSN: 1553-7366